Nano, Encarnacion T.

HRN: 28-60-91  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/22/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
02/22/2026
03/01/2026
IV
300
Q6
Breast Mass
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: